Link Pharma Chem Limited (BOM:524748)
India flag India · Delayed Price · Currency is INR
26.63
+1.13 (4.43%)
At close: Nov 16, 2026

Link Pharma Chem Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
274.6274.32254.33298.98387.58535.61
Revenue Growth
6.04%7.86%-14.93%-22.86%-27.64%53.85%
Gross Profit
158.2161.41125.37126.05165.83163.53
Operating Income
1.395.05-8.14-16.8417.9525.74
Net Income
-2.450.77-10.27-13.636.5418.82
Earnings Per Share
-0.550.17-2.31-3.071.474.24
EPS Growth
-----65.23%73.45%

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1.495.880.650.640.942.68
Total Debt
45.673.0457.8292.2287.5763.88
Net Cash (Debt)
-44.12-67.17-57.18-91.58-86.63-61.2
Net Cash Growth
------
Net Cash Per Share
-9.83-15.13-12.88-20.62-19.51-13.78

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
28.3821.4726.86-0.28-17.07-12.59
Capital Expenditures
-13.84-21-2.57-9.5-8.93-11.56
Free Cash Flow
14.540.4724.29-9.78-26-24.15
Free Cash Flow Growth
--98.08%----

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
57.61%58.84%49.29%42.16%42.79%30.53%
Operating Margin
0.51%1.84%-3.20%-5.63%4.63%4.81%
Pretax Margin
-0.94%0.49%-5.51%-6.41%2.29%4.89%
Profit Margin
-0.89%0.28%-4.04%-4.56%1.69%3.51%
FCF Margin
5.30%0.17%9.55%-3.27%-6.71%-4.51%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
-130.85--24.859.50
P/FCF Ratio
8.13215.936.18---
PS Ratio
0.430.370.590.630.420.33